Glenmark Pharmaceuticals and Cosmo Pharmaceuticals have received MHRA approval to market Winlevi, a topical acne treatment ...

Glenmark Pharmaceuticals receives UK approval for Winlevi, a groundbreaking topical acne treatment with unique mechanism of ...

Spironolactone – sometimes called “spiro” for short – has been a miracle drug for many suffering from acne, PCOS, and hair ...

Glenmark Pharmaceuticals Ltd, in collaboration with Cosmo Pharmaceuticals N.V., has received approval from the UK Medicines ...

In this review, Feldman and colleagues evaluated data from 10 phase 2 and phase 3 clinical trials on seven different topical acne combination treatments to see which delivered the earliest ...

Monday said that Glenmark had received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi in the United Kingdom. Winlevi is the first topical acne treatment ...

Decision Point: What is an Appropriate Treatment Plan for This Particular Patient? Because the patient has noninflammatory and inflammatory lesions, a prudent first-line approach would be to ...

Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) and Glenmark Pharmaceuticals Limited (Glenmark), a global ...

Clinicians should consider using a topical retinoid for first-line management for acne treatment (Wolf, 2002). It reverses thickening of the stratum corneum and the abnormal desquamation of ...